In a decision that could potentially save countless lives, the Centers for Medicare and Medicaid Services (CMS) will provide insurance coverage through Medicare for lung cancer screening with low-dose computed tomography (CT). Around 10 million individuals at high-risk for developing lung cancer based on a personal history of tobacco use will benefit. […]
RadNet, Inc., a leading provider of high-quality, cost-effective diagnostic imaging services through a national network of 251 owned and/or operated outpatient imaging centers, announced that David W. Stoller, M.D., F.A.C.R, will host a continuing medical education (CME) workshop for orthopaedic imaging in Laguna Beach, California from December 13-14, 2014. This event offers radiologists, orthopedic surgeons and allied health care professionals the opportunity to receive exclusive instruction from Dr. Stoller, a well-renowned expert in sports imaging and the author of multiple influential textbooks on musculoskeletal (MSK) and orthopaedic imaging.
- The 2-day checklist workshop for orthopaedic imaging will aid radiologists, surgeons […]
For several decades, women have led an increasingly concerted effort to raise awareness around breast cancer and to demand better treatment options. It is time for men to do the same. […]
A recent study revealed great news for women facing early-stage invasive breast cancer: choosing to preserve some breast tissue rather than removing the entire breast isn’t inviting more risk.
Survival Rate is Higher with Lumpectomy vs Mastectomy
Even when coupled with various factors – age, socioeconomic status, race, tumor grade, proportion of positive nodes and year of diagnosis – women were less likely to die with […]
Is there a magic age after which a woman can terminate her screening mammogram?
In 2009 the United States Preventive Task Force (USPTF) controversially made a number of mammogram age guideline recommendations. These included the statement that there was insufficient evidence showcasing the benefits or harms of mammograms for older women. It also noted the need for additional randomized clinical trials to provide information comparing continued screening after the age of 75 with stopping screening (1).
A new study challenges this ideology and indicates that women over the age of 75 may no longer receive a free pass. This […]